| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |